United States
AT
AU
BE
CA
CH
CN
CZ
DE
DK
ES
FI
FR
GR
HR
HU
IE
IL
IN
IT
JP
NL
NO
PL
PT
RO
RU
SE
SK
TR
UK
ZA
Menu
Alert: Product and Recall NoticesMedtronic Looks Forward to Welcoming Companion Medical and the InPen to the Medtronic Family
Today, we look forward to welcoming Companion Medical, makers of the only FDA-cleared smart insulin pen system paired with an integrated diabetes management app, to the Medtronic family. The InPen system automatically records insulin doses, tracks active insulin, and recommends mealtime & correction doses based on a bolus calculator which helps simplify diabetes management*. Listen to this video message from Diabetes Group President Sean Salmon on his vision for simplifying diabetes management for people wherever they are in their journey.
Our vision for the future is to build upon the success of the InPen system by combining it with our intelligent algorithms to deliver proactive and personalized dosing advice. This smart CGM and pen system can help people think less about diabetes and enable them to live life with more freedom, on their own terms**.
We continue to make enhancements to our CGM platform to ensure a seamless experience for our customers regardless of how insulin is delivered. As a trusted partner, our goal is to offer consistent support whether an individual wants to stay on multiple daily injections, transition to automated insulin delivery or take a break from their pump.
Today, there are many people throughout the US, who benefit from the InPen system. We are inspired by these stories and want to share one from Kris Drewery, who has been living with diabetes for 18 years and is enjoying the confidence from the information he gets from the InPen system.
We are excited to partner with the team at Companion Medical and look forward to welcoming them to our family, once the acquisition has closed.
As always, we are grateful for the countless people living with diabetes around the world, who choose Medtronic to support them through their journey.
If you’re currently using the InPen system, you should continue to contact Companion Medical for any support or product needs. Companion Medical can be reached directly at 844-843-7903.
To learn more about Companion Medical and the smart insulin pen, visit: www.companionmedical.com
*User interaction, compatible device and proper device pairing and settings required.
**IMPORTANT: The Insights offered by InPen reports are intended to supplement, not replace, medical expertise in the self-administration of insulin for the treatment of diabetes. The report provides information that can be used to identify trends to inform treatment decisions. Reports are not intended to produce medical advice and should not be relied upon for such purpose.
IMPORTANT: The calculated dose is a suggestion. You decide whether to follow the suggestion or rely on your own judgment. The dose calculator cannot account for other factors like activity, illness, alcohol use, etc.
WARNING: Using the Dose Calculator with incorrect Therapy Settings or without all of your recent insulin logged may result in unsafe recommendations, which could lead to severe hyperglycemia, hypoglycemia, or injury.
IMPORTANT SAFETY INFORMATION
The InPen requires a prescription. It is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin. The pen injector is compatible with Lilly Humalog® U-100 3.0 mL cartridges, Novo Nordisk Novolog® U-100 3.0 mL cartridges, and Novo Nordisk Fiasp® U-100 3.0 mL cartridges and single-use detachable and disposable pen needles (not included). The pen injector allows the user to dial the desired dose from 0.5 to 30 units in one-half (1/2) unit increments.
The InPen dose calculator, a component of the InPen app, is indicated for the management of diabetes by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for calculating an insulin dose or carbohydrate intake based on user entered data.
For an insulin dose based on amount of carbohydrates, a healthcare professional must provide patient-specific target blood glucose, insulin-to-carbohydrate ratio, and insulin sensitivity parameters to be programmed into the software prior to use.
For an insulin dose based on fixed/variable meal sizes, a healthcare professional must provide patient-specific fixed doses/meal sizes to be programmed into the software prior to use.
Related Post
About Author
Amanda Griswold
Principal Specialist, Social MediaAmanda Griswold started working for Medtronic in 2005, after graduating with a degree in Journalism. She’s held a variety of roles including sales, professional relations and marketing. During this time she also obtained her MBA. Amanda became personally involved with diabetes when she met her husband, who has type 1 diabetes, in 2008. They have a unique story about how they met, which you can read about on the LOOP blog. Since she knows how diabetes affects someone, she’s passionate about making life easier while living with diabetes, from products on the market to customer service. Amanda enjoys spending time with her husband and three young children.
I have a future looking questions similar to those asked previously, but more detailed. I would. like to know:
-Will the InPen continue to be used by the Decom (G6) or the upcoming (G7; to be released by Dexcom this year or early 2021)?
-With the upcoming purchase of Companion Medical by Medtronics, will I need to switch to a Medtronics GCM or can I stay with
Dexcom GCM G6 or G7)?
I am aware that Dexcom or Companion Medical do not currently have answers to these questions. When do you expect we will know more. Please contact me by email at
Thank you!
Mitchell P. Kamins
Thank you for your interest, Mitchell. We do not have plans to discontinue the ability to use Dexcom with InPen. In addition, we anticipate working on the integration of Guardian Connect CGM sensor data with the InPen. We will share more details in the future.
dont think the video talked about the highlights. i still don’t know, as a pump user, how this will benefit me.
Peta, the InPen is intended for those on MDI and not using an insulin pump to manage their diabetes.
Disappointing to see a great technology in InPen being gobbled up by the diabetic care company with zero customer service. Medtronic is close to securing a monopoly which is very unfortunate.
Former InPen user out.
We’re sorry to hear you feel that way. We’re always looking for ways to do better. We’re committed to serving the diabetes community by creating quality products and providing excellent customer service. Please know we hear you and take this feedback to heart.
When will Medicare approve the use of the automatic portion of my pump.
Hi, Susan. At this time, we do not have a timeline available for Medicare coverage of our CGM products. We hope you’ll stay tuned for updates as they become available.
I’m sure once Medtronic gets its hands on this technology, they will quickly kill it in favor its own, inferior pump systems, just like they did when they acquired the XXXXXXXXX pump when they bought it from XXXXX. The spirit pump was far easier to use than the current 5x0G series pumps with its unnecessarily complicated menu structure. Mark my words, this is the end of the InPen and more good technology withheld from patients as Medtronic continues to buy up and eliminate its competition. Medtronic’s growth strategy & moto: If you can’t beat them, buy them (and then quietly dispose of them)!
Karl, we’re sorry to hear you feel that way. We’re always looking for ways to do better. We’re committed to serving the diabetes community by creating quality products and providing excellent customer service. Please know we hear you and take this feedback to heart.
Why do you call this the LOOP blog? Are you trying to take attention away from DIY Loop?
Mike, the name Loop was chosen to reflect our goals of a closed-loop system.
Is this for type 1 or type 2 diabetes?
Audrey, InPen is approved for those who require insulin to manage their diabetes, including people living with type 1 or type 2 diabetes.
When can we expect a flexible set for target BG for the miniMed in Auto Mode?
Thanks
Claus
Thanks for reaching out, Claus. Our teams are consistently working hard on new technology and innovations in an effort to make diabetes management easier and more personalized. We do not have additional updates to share at this time, but we hope you’ll stay tuned for more information.
I currently use the XXXXXXX XXXX XXX. Will the “syringe” caps I use now be able to be used on this new device or will they be different? Also, will there be a range of insulin brands (XXXXXXX fast acting)?
At this, we do not have any specifics to share, but hope you’ll stay tuned for more information.
I’d rather hear that the newer CGMs will talk to my 670G, not a phone. When will Medtronic get the G3 sensors approved by Medicare/Medicaid? Put this out to my email.
Thank you
We understand how important this is, Lawrence and look forward to sharing updates and solutions as they become available. We hope you’ll stay tuned for updates.
This Inpen is obviously a step behind the Guardian CGM and 670G pump System, I am assuming?
Marsha, the InPen is designed for those who prefer the use of an insulin pen over an insulin pump. The InPen is the only FDA-cleared smart insulin pen that combines the freedom of Bluetooth technology and intelligence through an easy to use app, helping people administer correction and meal-time insulin doses.
OMG they cant keep what they already have straight and they are going for more ! Say it isnt so. We will have more items we need held up at their whim and price gouging galore . They are terrible now how much worse will-it get ?
I’m sorry to hear your thoughts, Sandy. We’re excited about the possibilities this acquisition can have for supporting our customers regardless of where they are their diabetes journey. If you have concerns that you’d like to discuss, please send us a brief description, along with the phone number associated with your account to dhelp@medtronic.com and we’ll get you connected with a teammate.
My questions is the pen connected with a phone app or its it connected to another device that one would have to carry at all times?
Ruth, the InPen is the only FDA-cleared smart insulin pen that combines the freedom of Bluetooth technology and intelligence through an easy to use app, helping people administer correction and meal-time insulin doses.
Will this work with the medtronic XX remote insulin pump?
Thanks, Dave. We anticipate working on integration of Guardian Connect CGM sensor data with the InPen. We will share more details in the future.
Does this work with a CGM. I currently have an insulin pump 670G. Not sure if this would benefit me or not since the pump continually offers insulin as needed.
Wondering if the I PEN app would work for me to use when deciding what bolus to take when i eat a meal outside my home. When i eat at home i know how many carbs i am ingesting, not so much so when eating outside the home.
Thanks,
Steve
Thanks for the question, Steve. The InPen works for people who are on multiple daily injections. It’s the only FDA-cleared smart insulin pen helping people administer correction and meal-time insulin doses. We anticipate working on integration of Guardian Connect CGM sensor data with the InPen. We will share more details in the future.
Please tell me what progress in being made on making the 670g “Medicare” compliant? Some of the information I have read about the XXXX suggests that it might meet the “Medicare” standards. I will be eligible for a new pump Nov. 2020 (warranty). I was hoping to transition to the XXXX then, but from what I am now reading that the XXXX will not be available in the U.S. for awhile.
We appreciate you reaching out, Bill. We are working on non-adjunctive labeling, but at this time, a timeline is not available. We understand the importance of our technologies and look forward to sharing updates as they become available.
I do not like pen I like insulin pump. Medtronic is continue making insulim pump??
Yes, Maria. We want to offer support to people no matter their preference for insulin delivery systems. More details will be available after the transaction is complete and integration work is underway.